Skip to main content
Strategic Partners A/S logo

Strategic Partners A/S — Investor Relations & Filings

Ticker · STRAP ISIN · DK0062502894 LEI · 54930025OZD2GGSQ7L42 CO Financial and insurance activities
Open in API
Filings indexed 501 across all filing types
Latest filing 2020-04-17 Director's Dealing
Country DK Denmark
Listing CO STRAP

About Strategic Partners A/S

https://www.strategic-partners.dk/

Strategic Partners A/S is an investment company that engages in strategic partnerships with businesses that have significant potential. The company's strategy involves taking an active ownership role to create value through its competencies. In addition to its primary focus, the firm may also invest in other equity interests and properties to generate returns. Formerly known as Orphazyme A/S, the company sold its biotechnology activities in May 2022. A new board and management team was appointed in May 2023, and the company officially adopted its new strategy, purpose, and name in October 2024.

Recent filings

Filing Released Lang Actions
Director's Dealing 2020
Director's Dealing Classification · 100% confidence The document is explicitly titled "Reporting of transactions in Orphazyme's shares made by persons discharging managerial responsibilities." It details specific transactions (exercise of restricted share-units) conducted by the Deputy Chairman of the Board of Directors and a Member of the Board of Directors on April 15, 2020. This type of filing, reporting insider trading or personal share transactions by executives/directors, directly corresponds to the definition of 'Director's Dealing' (DIRS). The reference to 'Market Abuse Regulation article 19' further confirms this regulatory context.
2020-04-17 English
Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities
Director's Dealing Classification · 100% confidence The document is a formal notification regarding share transactions by persons discharging managerial responsibilities (PDMRs), specifically the Deputy Chairman and a Board member of Orphazyme A/S. It explicitly cites the Market Abuse Regulation (MAR) article 19, which governs insider dealing and director transactions. This aligns perfectly with the definition of 'Director's Dealing' (DIRS).
2020-04-17 English
Orphazyme publishes listing prospectus in connection with listing of shares
Share Issue/Capital Change Classification · 95% confidence The document is a short announcement (under 5,000 characters of core content) from Orphazyme A/S regarding the publication of a listing prospectus. It explicitly states that the prospectus is available via a link and provides context for the listing of shares. Following the 'Menu vs Meal' rule, this is an announcement of a report/document rather than the document itself, making it a Report Publication Announcement (RPA).
2020-03-16 English
Share Issue/Capital Change 2020
Share Issue/Capital Change Classification · 95% confidence The document is explicitly titled "Orphazyme publishes listing prospectus in connection with listing of shares." It discusses the publication of a "listing prospectus" related to the admission of shares to trading on Nasdaq Copenhagen A/S. A prospectus is a formal legal document required for public offerings or listings. Since the document's primary purpose is announcing the availability of this specific legal document (the prospectus) related to a capital market event (the listing), it falls under the category of documents related to financing or capital structure changes. However, the document itself is an announcement *about* the prospectus, not the prospectus itself, nor is it a general earnings release or a standard regulatory filing (RNS). The closest fit among the provided definitions is 'Capital/Financing Update' (CAP), as a listing prospectus is central to a financing/capital structure event. Alternatively, since it is an announcement of a specific legal document related to securities, it could be considered a specialized regulatory filing. Given the focus on the 'listing prospectus' and the context of the Offering mentioned, CAP is a strong candidate. However, the document explicitly states it is a 'Company announcement' and details the publication of a prospectus, which is a key document in capital raising/listing activities. If we consider the prospectus itself, it relates to capital. If we consider the announcement of the prospectus, it is a corporate action announcement. Since the document is about the publication of a prospectus related to a share listing, which is a capital event, CAP is appropriate. If the document were a general regulatory filing that didn't fit elsewhere, RNS would be used. Given the specific nature of the document announcing the availability of a prospectus for a listing, CAP (Capital/Financing Update) is the most precise fit describing the underlying corporate action being announced.
2020-03-16 English
Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities
Director's Dealing Classification · 100% confidence The document is a formal notification of share transactions by a person discharging managerial responsibilities (Bo Jesper Hansen, Deputy Chairman of the Board). It explicitly cites the Market Abuse Regulation (MAR) article 19, which governs insider dealing and director transactions. This aligns perfectly with the definition of 'Director's Dealing' (DIRS).
2020-03-11 English
Director's Dealing 2020
Director's Dealing Classification · 100% confidence The document explicitly states it is a 'Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities' and details the purchase of shares by a Deputy Chairman of the Board of Directors (Bo Jesper Hansen). This directly corresponds to the definition of Director's Dealing (insider trades by executives/directors). The filing type code for this is DIRS.
2020-03-11 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.